Medius Holdings Co., Ltd. AI Stock Analysis
Want to see JP:3154 full AI Analyst Report?
Medius Holdings Co., Ltd. (3154) AI Stock Analysis
Medius Holdings Co., Ltd.
(TSE/TYO:3154)
Medius Holdings receives a neutral overall score heavily weighed down by deteriorating profitability and negative free cash flows, despite consistent revenue expansion. Weak technical indicators suggest continued bearish momentum, though a reasonable valuation and a 2.56% dividend yield offer a buffer. Management's ability to improve operating margins and cash conversion will be critical for a more positive outlook.
Medius Holdings Co., Ltd. (3154) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 16.14B
- Dividend Yield
- 2.75%
- Average Volume (3M)
- 26.59K
- Price to Earnings (P/E)
- 15.2
- Beta (1Y)
- 0.58
- Revenue Growth
- 5.05%
- EPS Growth
- -24.77%
- Country
- Japan
- Employees
- 2,716
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Distribution
Medius Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Medius Holdings Co., Ltd. is a Japanese enterprise deeply embedded in the healthcare sector. The company's operations involve the distribution of a diverse range of medical devices, encompassing fundamental consumables such as syringes and gauze, as...
How the Company Makes Money
Medius Holdings primarily makes money through the sale and distribution of medical devices and related medical consumables to healthcare providers (e.g., hospitals and clinics). Revenue is generated when the company procures products from manufacture...
Medius Holdings Co., Ltd. Financial Statement Overview
Summary
The company shows robust top-line revenue growth and maintains a conservative balance sheet with decreasing debt levels. However, this is significantly offset by systemic profitability issues, declining net income, razor-thin profit margins, and a recent shift to negative free cash flow.
Income Statement
45NeutralBalance Sheet
65PositiveCash Flow
40Negative| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 306.44B | 302.34B | 288.69B | 259.79B | 239.05B | 221.69B |
| Gross Profit | 35.59B | 35.82B | 33.30B | 31.09B | 29.31B | 27.42B |
| EBITDA | 4.34B | 4.01B | 4.77B | 3.86B | 4.27B | 3.80B |
| Net Income | 1.06B | 944.09M | 1.38B | 1.12B | 1.50B | 1.87B |
Balance Sheet | ||||||
| Total Assets | 117.60B | 112.59B | 113.54B | 115.34B | 97.73B | 93.15B |
| Cash, Cash Equivalents and Short-Term Investments | 10.91B | 10.05B | 14.33B | 13.64B | 10.33B | 9.11B |
| Total Debt | 23.93B | 18.39B | 21.89B | 24.57B | 19.70B | 17.98B |
| Total Liabilities | 96.91B | 91.85B | 93.06B | 95.60B | 79.15B | 75.84B |
| Stockholders Equity | 20.67B | 20.74B | 20.48B | 19.74B | 18.57B | 17.31B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -373.71M | 5.26B | 261.12M | 300.65M | -8.49B |
| Operating Cash Flow | 0 | 374.23M | 7.01B | 1.92B | 1.22B | -3.90B |
| Investing Cash Flow | 0 | -1.26B | -2.51B | -2.67B | -862.94M | -4.82B |
| Financing Cash Flow | 0 | -3.40B | -3.47B | 4.01B | 862.90M | 5.21B |
Medius Holdings Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3154, the sentiment is Negative. The current price of 726.00 is below the 20-day moving average (MA) of 736.50, below the 50-day MA of 764.40, and below the 200-day MA of 794.39, indicating a bearish trend. The MACD of -14.92 indicates Negative momentum. The RSI at 41.00 is Neutral, neither overbought nor oversold. The STOCH value of 46.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3154.
Medius Holdings Co., Ltd. Peers Comparison
Overall Rating
JP:773079Outperform
JP:774772Outperform
JP:797966Neutral
JP:771660Neutral
JP:770256Neutral- JP:315450Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:7730 | 79Outperform | JPY 148.76B | 20.32 | ― | 2.75% | 10.18% | 55.86% |
| JP:7747 | 72Outperform | JPY 1.02T | 31.60 | 19.88% | 1.25% | 22.57% | 138.10% |
| JP:7979 | 66Neutral | JPY 80.75B | 12.86 | ― | 2.70% | 8.74% | 36.76% |
| JP:7716 | 60Neutral | JPY 246.40B | 102.71 | 1.89% | 2.04% | 17.25% | -40.40% |
| JP:7702 | 56Neutral | JPY 10.53B | -12.45 | ― | 3.92% | -3.10% | -645.12% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| JP:3154 | 50Neutral | JPY 16.03B | 15.22 | ― | 2.75% | 5.05% | -24.77% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:3154 | Medius Holdings Co., Ltd. | 726.00 | -66.48 | -8.39% | |
| JP:7747 | Asahi Intecc Co | 3811.00 | 1165.71 | 44.07% | |
| JP:7716 | Nakanishi | 1419.00 | 389.51 | 37.84% | |
| JP:7702 | JMS Co., Ltd. | 434.00 | 18.07 | 4.34% | |
| JP:7730 | Mani, Inc. | 1493.00 | 86.98 | 6.19% | |
| JP:7979 | Shofu Inc. | 2250.00 | 468.05 | 26.27% |
Medius Holdings Co., Ltd. Corporate Events
Medius Holdings Reports Strong First-Quarter Profit Growth
Medius Holdings Co., Ltd., listed on the Tokyo Stock Exchange’s Prime Market, reported consolidated net sales of ¥76.273 billion for the quarter ended September 30, 2026. The release does not specify the company’s industry, primary products, or servi...
Medius Holdings Issues Correction to First-Quarter Results
Medius Holdings Co., Ltd., listed on the Tokyo Stock Exchange’s Prime Market, announced a correction to its consolidated financial results for the first quarter ended September 30, 2025. The company said certain items in its previously disclosed resu...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026